Trademark Attorney / Law Firm

Colin McMullin – Trademark Portfolio

Colin McMullin specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 7 of 9 total filings concentrated in this category. The practice also covers Class 25 (Clothing) along with 3 other Nice Classification classes. Filing activity spans from 2017 to 2019. Currently, 1 trademark is registered.

9 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Colin McMullin's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

25
Clothing (5 filings)

Clothing, footwear, headgear

32
Light Beverages (4 filings)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

Frequently Asked Questions

How many trademark applications has Colin McMullin filed?

Colin McMullin has filed 9 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 3 abandoned, 5 cancelled.

What trademark classes does Colin McMullin specialize in?

Colin McMullin has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

How long has Colin McMullin been filing trademarks?

Colin McMullin's trademark filing history with the USPTO spans from 2017 to 2019, covering 2 years of trademark practice. During this period, Colin McMullin has handled 9 trademark applications.

What is Colin McMullin's trademark registration success rate?

Colin McMullin has a 11% trademark registration rate, with 1 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.